Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Jefferies Downgrades Albireo Pharma to Hold, Lowers Price Target to $42

Author: Benzinga Newsdesk | January 11, 2023 05:52am
Jefferies analyst Eun Yang downgrades Albireo Pharma (NASDAQ:ALBO) from Buy to Hold and lowers the price target from $49 to $42.

Posted In: ALBO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist